Dr Abeer Shaaban

Queen Elizabeth Hospital Birmingham & University of Birmingham

Dr Shaaban is a specialist breast pathologist at Queen Elizabeth Hospital Birmingham and Honorary Senior Lecturer at the University of Birmingham. She is Breast Pathology Clinical Advisor for West Midlands, Member of Big 18 group, Lead of NCRI CM-PATH Workstream 2 (clinical trials) and member of the International Committee of the Royal College of Pathologists.

She completed her PhD in molecular pathology at the University of Liverpool, did her pathology training at the West Midlands and Yorkshire regions before working as consultant pathologist in Leeds then Birmingham. She has led and contributed to a number of breast research studies and breast cancer trials and
published over 100 papers in the field. Dr Shaaban was member of the NCRI breast CSG and chair of the Translational Subgroup of the NCRI Breast Clinical Studies Group.

dont miss

Breast Pathology: Assessing tumour response to neoadjuvant chemotherapy and endocrine therapy– Pathological considerations

The seminar will cover issues related to the multidisciplinary approach and pathological handling of neoadjuvant chemotherapy specimens, methods of histological assessment, importance of radiological correlation and recent developments including tumour bed biopsies.

EVEN MORE SEMINARS

  • Dr Paul Fenton: Speaking at the Oncology Convention

    Dr Paul Fenton
    University Hospital Southampton NHS Foundation Trust

    Rapid Access Multidisciplinary Palliative Assessment and Radiotherapy Treatment (RAMPART) clinic

  • Lucy Thompson ft. Stacie-rae Weir: Speaking at the Oncology Convention

    Lucy Thompson ft. Stacie-rae Weir
    Nipple Innovation Project

    Healing power of permanent realism in restorative tattooing

  • Professor Robert Thomas: Speaking at the Oncology Convention

    Professor Robert Thomas
    Bedford and Addenbrooke's Cambridge University Hospitals

    Evidence based lifestyle strategies after cancer - a research review

  • Dr Natalie Cook: Speaking at the Oncology Convention

    Dr Natalie Cook
    University of Manchester/Christie NHS Foundation Trust

    Molecular testing and novel therapies in prostate cancer

  • Professor Noel Clarke: Speaking at the Oncology Convention

    Professor Noel Clarke
    The Christie and Salford Royal Hospitals, Manchester UK

    Improving Prostate Cancer Outcomes Through Cancer Trials